Omadacycline Suppliers & Bulk Manufacturers

Available Forms: Tablet/ Injection

Available Strengths: 100 mg, 150 mg

Reference Brands: Nuzyra (USA/EU)

Category: Antibiotics

Omadacycline is available in Tablet/ Injection and strengths such as 100 mg, 150 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Omadacycline is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Omadacycline can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Omadacycline is a broad-spectrum antibiotic used to treat adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). It belongs to the aminomethylcycline subclass of tetracycline antibiotics and is effective against a wide range of Gram-positive and Gram-negative bacteria. Omadacycline works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and helping the body eliminate infection.

Sold under the brand name Nuzyra, omadacycline is available in both oral and intravenous formulations, offering flexibility for patient treatment and hospital settings. It is designed specifically to target bacterial infections and is not effective against viral infections such as colds or the flu. Approved in the United States in October 2018, omadacycline provides a valuable treatment option for patients who may have limited responses to other antibiotics. Its broad-spectrum activity, combined with its oral bioavailability and well-tolerated safety profile, makes it a preferred choice for physicians managing community-acquired pneumonia and skin infections.